The FDA has explicitly stated that a "research use only" label does not exempt a product from FDA requirements when the product is marketed or intended for human use [14][15]
Commercial insurance coverage for GLP-1 weight-loss medications has expanded in 2024-2026 - many large employers added coverage - but coverage remains uneven and typically requires prior authorization for obesity indications
At Highland Longevity, we look beyond TSH to understand your complete thyroid picture: Free T4 and Free T3 levels (the active hormones) Reverse T3 (which can block T3 action) Thyroid antibodies (for Hashimoto's assessment) Metabolic rate testing via RMR Body composition via DEXA scan This comprehensive approach helps us understand whether your thyroid treatment is truly optimizedand how semaglutide can best support your weight loss goals
PossoOsorio, I., VargasPotes, C
For instance, other GLP-1 receptor agonists and medications affecting the central nervous system or blood pressure may also lead to dizziness
Improves Insulin Sensitivity and Glucose Regulation MOTSc increases the translocation of GLUT4 (glucose transporter) to muscle cells, enhancing glucose uptake without needing insulin spikes